Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Corundum Systems Biology appoints Jessica Schneider as Chief Scientific Officer

She joins Corundum Systems Biology from Takeda Ventures where she managed investment in novel therapeutic modality platforms, having previously served as Director of Takeda Pharmaceuticals' Gastroenterology Drug Discovery Unit where she helped...

PANTHERx® Rare is selected by Calliditas Therapeutics as the specialty pharmacy for TARPEYO®.

age at diagnosis, with a median time to kidney failure of approximately 10 years. TARPEYO is an oral 4mg delayed release formulation of budesonide, designed to remain intact until it reaches the ileum. Each capsule contains coated beads of...

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information please visit www.emdgroup.com.

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

available to support individuals and families by addressing clinical-related questions, assisting customers in making informed healthcare decisions and offering consultations on vaccination history. Most pharmacy locations offer evening and weekend...

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

additional equipment or reagents. The all-in-one kit includes all reagents for DNA extraction in a plate or microfuge tube format, AccuRes PCR master mix, primer/probe mix, and DNA standard – all with demonstrated sensitivity (a limit of detection...

ProJenX announces the formation of its Clinical Advisory Board

pathways for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, announced the formation of its Clinical Advisory Board (ClAB). The ClAB, which includes internationally renowned experts in clinical trial...

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

digital pathology workflows: Ibex’s Prostate AI solution, integrated into Proscia’s Concentriq® enterprise pathology platform, allowed pathologists at Quest Diagnostics to be able to sign out significantly more cases per hour. The offering was...

Find Therapeutics announces FDA clearance of its IND application for a Phase 1 study of FTX-101 to treat chronic optic neuropathy

from Strasbourg University on a technology and related know-how initially developed by Dr. Dominique Bagnard. For more information please Visit www.findtherapeutics.com

China approves the Corina Intrauterine Drug-Eluting System as a novel treatment for moderate-to-severe intrauterine adhesions (IUA)

intrauterine re-adhesion risk post TCRA, and the improvement of endometrial growth. Intrauterine adhesions (IUA) are the formation of scar tissues in the endometrial cavity as a result of damages to the endometrial basal layer of the uterus, which...

Trinity Life Sciences introduces new customer engagement solutions, leveraging its deep commercial insight and renowned technology platform

new Customer Engagement solutions leveraging both Trinity’s deep commercial insight and recognized technology platform. The new offerings are designed to help life sciences organizations with novel customer engagement solutions including adaptive...

ImmPACT Bio announces FDA clearance of its IND application for CD19/CD20 bispecific CAR-T cell therapy in multiple sclerosis

biopharmaceutical company developing a new generation of cellular therapies that have the potential to bring transformational benefits to patients, announced the United States Food and Drug Administration (FDA) has cleared an investigational new...

26th Asia-Pacific League of Associations for Rheumatology Congress 2024

to be an exceptional gathering, embracing the vibrant spirit of Singapore and fostering an immersive in-person congress format. Join us as we celebrate not only the remarkable hospitality of our Singaporean colleagues but also commemorate a pivotal...

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

the way forward to improve the lives of people living with liver disease around the world. We have helped to transform hepatitis C from a chronic condition into one that can be cured for millions of people. For people living with hepatitis B or D,...

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

XiFin, Inc., a leading provider of innovative healthcare information technologies and services that deliver artificial intelligence (AI)-enabled operational efficiency, interoperability, and simplicity, announced that it has unified its products...

Aptar’s Nasal Unidose System will deliver neffy® (epinephrine nasal spray), the first FDA-approved needle-free treatment for Type I allergic reactions, including anaphylaxis

medications that help promote adherence and ease of use for patients.” Unidose (UDS) and Bidose (BDS) Technology Platforms: Aptar’s UDS and BDS technology platforms are designed to be robust, reliable and intuitive systems for easy administration...

Bavarian Nordic gets a HERA order and announces a major vaccine donation for the Mpox outbreak in Africa

enhance public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. For more information visit www.bavarian-nordic.com.

Spencer Trask & Co. launches Signal12 for Dry Eye Disease treatment, led by former Aerie executives, advancing Pro-ocular through trials

Thomas Mitro was recruited by Spencer Trask to lead Signal12 as president and chief executive officer. Mitro is the former president and chief operating officer of Aerie Pharmaceuticals, where he grew annual sales to more than $100 million and...

Persist AI and Nivagen partner to develop AI-driven manufacturing for long-acting injectables

to co-develop a next-generation manufacturing process for long-acting injectable (LAI) drugs, using Persist's AI-based formulation technology and Nivagen's manufacturing capabilities. The collaboration aims to simplify and accelerate the...

Stay Protected

and home and garden content, Family Features provides readers with topically and seasonally relevant tips, takeaways, information, recipes, videos, infographics and more. For more information please visit,www.Culinary.net

Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma

T-cell Lymphoma: Cutaneous T-cell lymphoma is a type of cutaneous non-Hodgkin lymphoma (NHL) that comes in a variety of forms and is the most common type of cutaneous lymphoma. In CTCL, T-cells, a type of lymphocyte that plays a role in the immune...